论文部分内容阅读
目的:探讨甘精胰岛素联合二甲双胍治疗2型糖尿病的应用效果。方法:接收在我院患有2型糖尿病的患者一共有82例,随机分为治疗组、对照组,对照组对病人实施二甲双胍进行治疗,治疗组在此基础之上采取甘精胰岛素进行治疗,对比两组病人的治疗效果。结果:治疗前,两组病人的血糖和糖化血红蛋白水平之间的差异不具有统计学意义(P<0.05),治疗后,治疗组病人的血糖和糖化血红蛋白水平明显低于对照组(P<0.05)。结论:2型糖尿病采取甘精胰岛素联合二甲双胍共同治疗,可以将病人的血糖控制在有效范围以内,使发生低血糖的几率明显降低,具有临床推广价值。
Objective: To investigate the effect of glargine plus metformin on type 2 diabetes mellitus. Methods: A total of 82 patients with type 2 diabetes mellitus received in our hospital were randomly divided into treatment group, control group and control group. Metformin was administered to patients. On the basis of this, treatment group took insulin glargine for treatment, Compare the treatment effect of two groups of patients. Results: Before treatment, the difference of blood glucose and HbA1c in both groups was not statistically significant (P <0.05). After treatment, the levels of blood glucose and HbA1c in patients in treatment group were significantly lower than those in control group (P <0.05 ). Conclusion: Type 2 diabetes treated with insulin glargine combined with metformin can control the patient’s blood glucose within the effective range, so that the incidence of hypoglycemia significantly reduced, with clinical value.